Bangalore, September 27, 2025: ThePharmaTimes.in Appoints Mr. Subash Chandran Gopinathan Nair as Director – Operations ThePharmaTimes.in, one of the most respected and trusted news portals of south east Asia dedicated to the pharmaceutical and healthcare industry, is proud to announce the appointment of Mr. Subash Chandran Gopinathan Nair as Director – Operations.
Mr. Nair brings with him more than 36 years of rich experience in pharmaceutical marketing, hospital administration, and healthcare management. He has served in key leadership roles across the healthcare spectrum, most recently as the Chief Executive Officer of Madhu Hospital, Adoni, where he successfully spearheaded hospital modernization, patient-centric initiatives, and digital transformation projects. His career also includes a distinguished track record in pharmaceutical sales, product promotion, strategic planning, and healthcare branding across Andhra Pradesh, Telangana, and Kerala
Commenting on his new role, Mr. Nair saiid
“I am honoured to join ThePharmaTimes.in, a platform that has consistently upheld credibility and thought leadership in the pharma and healthcare domain. I look forward to contributing to its growth by strengthening operations, driving impactful initiatives, and enhancing its value to readers, advertisers, and industry stakeholders.”
Welcoming him to the team, Mr. Khazi Altaf Hussain, Managing Editor of ThePharmaTimes.in, said:
“We are delighted to have Mr. Nair on board. His extensive expertise in healthcare operations and pharmaceutical marketing will add immense strength to our vision of making ThePharmaTimes.in not only an authoritative voice in the industry but also a platform that bridges knowledge, innovation, and growth for the pharma community.”
With Mr. Nair’s appointment, ThePharmaTimes.in further reinforces its commitment to serving as a premier source of in-depth news, insights, and analysis for the pharmaceutical and healthcare ecosystem in India and beyond.
Corporate Comm India (CCI Newswire)
